17h
Zacks Investment Research on MSNZimmer Biomet Focuses on Innovation Amid Growing CompetitionZimmer Biomet Holdings, Inc. ZBH is participating in the ongoing American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting in San Diego, from March 10-14. Here, the company is highlighting ...
In a report released today, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report).
Assetmark Inc. decreased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 67.7% in the 4th quarter, ...
This was the stock's second consecutive day of losses.
2d
Zacks Investment Research on MSNZBH Stock to Gain From Global Expansion Amid Difficult FX ScenarioZimmer Biomet ZBH continues to gain from procedure strength, strong execution and solid momentum in innovation. Yet the stock ...
Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...
The global Orthopedic Devices Market , valued at US$49.63 billion in 2023, is forecasted to grow at a robust CAGR of 14.5%, reaching US$51.61 ...
Zimmer Biomet CPT ® Hip System implants may put patients at an increased risk of suffering a broken thigh bone near the device. In some cases, patients may even need to undergo corrective surgery. At ...
WARSAW, Ind. - Zimmer Biomet Holdings, Inc. (NYSE:ZBH), a notable player in the medical technology industry with a market capitalization of $20.89 billion and impressive gross profit margins of 71.6%, ...
WARSAW, Ind., Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the ...
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results